Literature DB >> 19962324

Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine.

Renske van Delft1, Danielle Lambrechts, Pauline Verschuure, Jacques Hulsman, Marian Majoie.   

Abstract

PURPOSE: To investigate whether it is better to use blood beta-hydroxybutyrate (BHB) or urinary ketones to monitor ketogenic diet (KD).
METHOD: In 33 patients on KD we measured ketosis in two different ways. At the 3-monthly visits to the clinic we measured BHB in capillary blood obtained by finger-prick and the level of ketones in the urine using a urine dipstick. If the patient was able to collect urine, the urinary ketones were also measured every day at home. We compared the degree of ketosis with seizure reduction.
RESULTS: BHB measured during the 3-monthly visits correlated with seizure reduction at 3 and 6 months (p=0.037 and 0.019, respectively). Urinary ketones measured at the same time did not correlate at any visit. The averaged values of the daily measured ketones in the urine did not correlate either.
CONCLUSIONS: BHB correlates better with seizure reduction than do ketones in urine. It is, therefore, better to use BHB to monitor KD even if BHB is measured less frequently than urinary ketones. Copyright 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962324     DOI: 10.1016/j.seizure.2009.10.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  31 in total

Review 1.  Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Authors:  Susan A Masino; Jong M Rho
Journal:  Brain Res       Date:  2018-06-06       Impact factor: 3.252

2.  Histone Butyrylation/ Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells after a Long Term Metabolic Reprogramming.

Authors:  Fatemeh Mehdikhani; Hossein Ghahremani; Saeedeh Nabati; Hanieh Tahmouri; Majid Sirati-Sabet; Siamak Salami
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

3.  Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes.

Authors:  Jennifer D Merrill; Diana Soliman; Nitya Kumar; Sooyoung Lim; Afreen I Shariff; William S Yancy
Journal:  Diabetes Spectr       Date:  2020-05

Review 4.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 5.  Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

Authors:  Timothy A Simeone; Kristina A Simeone; Carl E Stafstrom; Jong M Rho
Journal:  Neuropharmacology       Date:  2018-01-08       Impact factor: 5.250

6.  Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet.

Authors:  A Berrington; K C Schreck; B J Barron; L Blair; D D M Lin; A L Hartman; E Kossoff; L Easter; C T Whitlow; Y Jung; F-C Hsu; M C Cervenka; J O Blakeley; P B Barker; R E Strowd
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

7.  Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.

Authors:  Iwona Chmiel-Perzyńska; Renata Kloc; Adam Perzyński; Sławomir Rudzki; Ewa M Urbańska
Journal:  Neurotox Res       Date:  2010-09-14       Impact factor: 3.911

Review 8.  The ketogenic diet: metabolic influences on brain excitability and epilepsy.

Authors:  Andrew Lutas; Gary Yellen
Journal:  Trends Neurosci       Date:  2012-12-08       Impact factor: 13.837

9.  How does the ketogenic diet work? Four potential mechanisms.

Authors:  Nika N Danial; Adam L Hartman; Carl E Stafstrom; Liu Lin Thio
Journal:  J Child Neurol       Date:  2013-05-13       Impact factor: 1.987

10.  Anticonvulsant effect of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy.

Authors:  Jianping Si; Shaohui Wang; Ning Liu; Xiaofei Yang; Ying Wang; Ling Li; Jiwen Wang; Xin Lv
Journal:  Exp Ther Med       Date:  2017-06-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.